p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.
Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hunstein W, Lichter P.
Döhner H, et al. Among authors: stilgenbauer s.
Blood. 1995 Mar 15;85(6):1580-9.
Blood. 1995.
PMID: 7888675
Free article.